From the Departments of Medicine (Cardiology Section) and § Anatomy, University of Wisconsin, Madison, Wisconsin 53792
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Mutations in HERG are associated with human chromosome 7-linked congenital long QT (LQT-2) syndrome. We used electrophysiological, biochemical, and immunohistochemical methods to study the molecular mechanisms of HERG channel dysfunction caused by LQT-2 mutations. Wild type HERG and LQT-2 mutations were studied by stable and transient expression in HEK 293 cells. We found that some mutations (Y611H and V822M) caused defects in biosynthetic processing of HERG channels with the protein retained in the endoplasmic reticulum. Other mutations (I593R and G628S) were processed similarly to wild type HERG protein, but these mutations did not produce functional channels. In contrast, the T474I mutation expressed HERG current but with altered gating properties. These findings suggest that the loss of HERG channel function in LQT-2 mutations is caused by multiple mechanisms including abnormal channel processing, the generation of nonfunctional channels, and altered channel gating.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The congenital long QT syndrome is a disorder associated with delayed cardiac repolarization and prolonged electrocardiographic QT intervals and the development of ventricular arrhythmias (torsades de pointes) and sudden death (1). One cause of congenital long QT syndrome is mutation in the human ether-a-go-go-related gene (HERG) producing chromosome 7-linked congenital long QT syndrome (LQT-2)1 (2). HERG encodes a voltage-gated potassium channel (3). HERG channel current has been shown to have properties similar to the rapidly activating delayed rectifier K+ current (IKr), and it plays an important role in cardiac action potential repolarization in the mammalian heart (4-6). HERG channels are also an important target for block by many drugs, and suppression of HERG current causes action potential prolongation and cardiac arrhythmias (5-12). Therefore, HERG channels have emerged as an important cardiac ion channel.
More than 30 HERG mutations have been identified in LQT-2 patients (2, 13-18). The electrophysiological properties of a few LQT-2 mutations have been studied in Xenopus oocytes, where they have been shown to result in reduced or absent HERG current (19). Although the molecular basis for some congenital human diseases is known to involve multiple mechanisms including defective protein processing and abnormal protein function, the molecular basis for long QT syndrome has not been studied. In the present work, we used electrophysiological, biochemical, and immunohistochemical methods to study intracellular protein processing and functional properties of wild type and five LQT-2 mutant HERG channels. Our findings show that some mutant HERG proteins are not processed to the mature form of the channel. Other mutant HERG proteins undergo normal processing but do not form functional channels, or they gate abnormally. These findings provide new information about the molecular mechanisms for the failure of mutant LQT-2 channels to generate normal HERG current.
![]() |
EXPERIMENTAL PROCEDURES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Site-directed Mutagenesis and Transfection-- The HERG LQT-2 mutations shown in Table I were generated by site-directed mutagenesis using the Altered Site II in vitro mutagenesis system (Promega, Madison, WI). Each mutation was verified by DNA sequencing using automatic DNA sequencer. Wild type and mutant cDNAs were subcloned into pcDNA3 vector (Invitrogen, Carlsbad, CA), and HEK 293 cells were transfected transiently or stably with these constructs using a lipofectamine method as described previously (6). After transient transfection, HEK 293 cells were studied at 48 h. When transiently transfected cells were used for patch clamp experiments, green fluorescent protein cDNA (1 µg) was co-transfected with HERG cDNA (5 µg) to serve as an indicator. In our experiments, >90% of green fluorescent protein-positive cells express HERG channels. For LQT-2 mutants, we established four stable cell lines (T474I, I593R, Y611H, and G628S). LQT-2 mutant stably transfected cell lines were selected by their G418 resistance and identified by the presence of HERG protein on Western blot. A mock-transfected (pcDNA3 vector) cell line was selected by its G418 resistance.
HERG Antibody-- The HERG protein antibody was generated using a fusion protein as antigen. The cDNA fragment of HERG encoding 181 amino acid residues from the carboxyl terminus was subcloned into the pET-32a vector (Novagen, Madison, WI) to make a histidine-tagged thioredoxin-HERG fusion construct. This construct was expressed in Escherichia coli AD494(DE3)pLysS strain (Novagen). The histidine-tagged thioredoxin-HERG fusion protein was purified using the His-Bind Buffer Kit (Novagen). The purified fusion protein was injected into rabbits to generate polyclonal antibody using a standard method (21). The specificity of the polyclonal anti-HERG antibody was tested by Western blot, immunohistochemical, and immunoprecipitation assays. Western blot showed that the HERG antibody recognized HERG protein bands only in HERG-transfected HEK 293 cells and not in mock-transfected or untransfected HEK 293 cells, and this reaction was inhibited when the HERG antibody was preincubated with the fusion protein. In addition, preimmune rabbit serum did not recognize HERG protein on Western blot. Immunofluorescence experiments demonstrated positive fluorescence staining only in HERG-transfected HEK 293 cells and not in mock-transfected and untransfected cells. Immunoprecipitation experiments also showed the absence of detectable HERG protein bands in mock-transfected cells.
Patch Clamp Recordings-- Membrane currents were recorded in whole cell configuration using suction pipettes as described previously (6, 22). Cells were superfused with HEPES-buffered Tyrode solution containing (in mM) 137 NaCl, 4 KCl, 1.8 CaCl2, 1 MgCl2, 10 glucose, and 10 HEPES (pH 7.4 with NaOH). The internal pipette solution contained 130 mM KCl, 1 mM MgCl2, 5 mM EGTA, 5 mM MgATP, 10 mM HEPES (pH 7.2 with KOH). All experiments were performed at 22-23 °C. Data are presented as mean ± S.E. Student's t test was used for statistical analysis.
Western Blot Analysis-- Membrane protein preparation and Western blot procedures were previously described (6). The membrane proteins were subjected to SDS-polyacrylamide gel electrophoresis and then electrophoretically transferred onto nitrocellulose membranes. The nitrocellulose membranes were incubated with the HERG antiserum (1:20,000 dilution) at room temperature overnight, and the antibody was detected with an ECL detection kit (6).
For proteinase K treatment of cells, wild type HERG- and LQT-2 mutant-transfected cells were washed with PBS and incubated with 2 ml of buffer containing 10 mM HEPES, 150 mM NaCl, and 2 mM CaCl2 (pH 7.4) with or without 200 µg/ml proteinase K (Sigma) at 37 °C for 30 min. The proteinase K activity was stopped by adding 1.3 ml of ice-cold PBS containing 6 mM phenylmethylsulfonyl fluoride and 25 mM EDTA. The cells were then harvested and washed three times with ice-cold PBS. The membrane proteins were isolated for Western blot analysis. For experiments using endoglycosidase H (Endo H) treatment, 30 µg of cell membrane protein was dissolved in 30 µl of 50 mM sodium citrate buffer (pH 5.5) containing 15 mMPulse-Chase Metabolic Labeling and Immunoprecipitation-- Wild type or mutant HERG-transfected cells were starved for 1 h in serum-free Dulbecco's modified Eagle's medium lacking methionine and cysteine and containing 0.25% bovine serum albumin. Cells were then incubated in the same medium containing [35S]methionine and [35S]cysteine (400 µci/ml). After 1 h of labeling, the medium was removed, and cells were washed and chased in Dulbecco's modified Eagle's medium with 2 mM unlabeled methionine and cysteine. At different time intervals, the cells were washed and lysed in 500 µl of immunoprecipitation buffer (50 mM Tris-HCl, pH 8.0 containing 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, and 0.1% SDS) with a protease inhibitor mixture (6). After centrifugation at 14,000 rpm for 5 min at 4 °C, the cell lysate was precleared by incubation with protein A-agarose beads (Pierce). HERG antiserum (1:100 dilution) was then added, and the mixture was incubated at 4 °C overnight. The antigen-antibody complexes were isolated with protein A-agarose beads. The immunoprecipitates were washed with the immunoprecipitation buffer. The bound antigen was eluted from the protein A-agarose beads by sample buffer (23), subjected to 7.5% SDS-polyacrylamide gel electrophoresis, and visualized with autoradiography.
Immunofluorescence Microscopy-- Wild type or mutant HERG-transfected cells were fixed with 4% paraformaldehyde for 20 min at room temperature. The cells were blocked with a buffer containing 5% goat serum, 0.2% Triton X-100, and 0.05% azide in PBS and then incubated with the HERG antiserum (1:3000 dilution) at 4 °C overnight. Following washing with PBS, the cells were incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG secondary antibody (Jackson, West Grove, PA) and washed with PBS. For double immunofluorescence staining experiments, cells were also incubated with a monoclonal antibody to BiP (Stressgen, Victoria, Canada) and Texas Red-conjugated goat anti-mouse IgG secondary antibody (Jackson, West Grove, PA). Immunofluorescence staining was viewed with a Nikon fluorescence microscope (Nikon, Tokyo, Japan).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Electrophysiological Properties of Wild Type and Mutant
Channels--
As shown in Table I, we
performed site-directed mutagenesis of HERG to generate five reported
LQT-2 mutations, T474I, I593R, Y611H, G628S, and V822M (2, 13-15) and
expressed these mutant HERG channels in HEK 293 cells. To study the
functional expression of the HERG wild type and mutant channels, we
performed patch clamp studies on transiently and stably transfected
cells. Patch clamp recordings using transient transfection are shown in
Fig. 1. Wild type HERG current showed
voltage-dependent activation with inward rectification at
more positive voltages as previously shown (6, 10). For mutants I593R,
Y611H, G628S, and V822M, no HERG current was recorded; rather, only a
small amplitude current endogenous to HEK 293 cells was present (6,
10). Similar results were obtained in stably transfected cells with the
mutants I593R, Y611H, and G628S (data not shown). In contrast, the
T474I mutation expressed functional channels but with altered gating properties. The T474I mutation activated at more negative voltages compared with wild type HERG channels. Similar results were obtained with stably transfected cells (data not shown). Fig. 1B
shows the activation curves for wild type and T474I mutant currents. When fit as a Boltzmann function, the half-maximal activation voltages
for wild type and the T474I mutation were 15.9 ± 1.1 mV
(n = 17 cells) and
43.2 ± 1.2 mV
(n = 16 cells), respectively (p < 0.05). The slope factors were 7.6 ± 0.3 and 6.8 ± 0.6, respectively (p > 0.05). Fig. 1C shows the
I-V plots of wild type and T474I mutant current density
measured at the end of the depolarizing step. It shows that the maximal
outward current in the T474I mutation was reached at
20 mV and that
for wild type it was reached at 0 mV. The maximal outward current
densities for wild type and T474I were 34.7 ± 4.0 and 26.6 ± 5.6 pA/pF, respectively (p > 0.05). Fig.
1C also shows marked inward rectification for both wild type
and T474I currents at more positive voltages, and in the voltage range
0-60 mV the current amplitudes for the T474I mutation were decreased
compared with wild type current amplitude (p < 0.05 at
each voltage). Fig. 1, B and C, also shows that
the threshold voltage for eliciting current was shifted negatively for
the T474I mutation.
|
|
Protein Processing Studied by Western Blot Analysis-- We have shown previously that wild type HERG channel protein expressed in HEK 293 cells consists of two forms on Western blot, a 135-kDa (lower) band and a 155-kDa (upper) band, and that both species involve N-linked glycosylation (6). We proposed that the upper band was the complexly glycosylated, mature form of the HERG channel and that the lower band was a core-glycosylated, precursor form of the HERG channel. In order to study the mechanisms accounting for dysfunctional mutant channels, we analyzed HERG channel proteins by Western blot as shown in Fig. 2. The HERG antibody did not recognize protein in mock-transfected cells, whereas it recognized HERG proteins in wild type-transfected and all five mutant-transfected cells. Wild type HERG, as well as the T474I, I593R, and G628S mutations, expressed two protein bands, a lower band at 135 kDa and an upper broad band at 155 kDa. These findings suggest that the T474I, I593R, and G628S mutations undergo protein processing similar to that of wild type HERG channels. In contrast, the Y611H and V822M mutations expressed only the lower protein band at 135 kDa without the upper protein band. The absence of the complexly glycosylated form of the channel in the Y611H and V822M mutants strongly suggests that a defect in protein processing causes failure of channel maturation.
|
|
|
Protein Processing Studied Using Metabolic Labeling-- To study the biosynthesis of wild type HERG and transport-deficient LQT-2 mutant proteins, we performed pulse-chase experiments using metabolic labeling. As shown in Fig. 5, the wild type HERG protein was initially synthesized as a precursor form of 135 kDa, which was gradually converted to a larger form of 155 kDa. These findings provide direct evidence for the precursor and product relationship of the 135- and 155-kDa bands of HERG channel protein found in Western blot experiments. The pulse-chase data also show that the rate of conversion of the precursor form to the mature form is relatively slow when compared with other membrane channel proteins expressed in mammalian cells (26, 27). For the Y611H, the mutant protein was initially synthesized as a 135-kDa form; however, it was not converted to a larger molecular mass form for chase times up to 24 h. Rather, the mutant protein underwent progressive degradation with the appearance of smaller molecular mass bands and with the nearly complete disappearance of the 135-kDa band by 24 h. These findings show that the Y611H mutation fails to generate the mature form of the channel protein and that the immature form of the channel protein is rapidly degraded.
|
Immunolocalization of Wild Type and Mutant HERG Channels-- We studied the subcellular localization of HERG protein in wild type and the five LQT-2 mutants by immunostaining permeabilized transfected HEK 293 cells. As shown in Fig. 6, the mock-transfected HEK 293 cells showed no detectable immunofluorescence staining. In cells transfected with wild type HERG, the immunofluorescence staining pattern is visible throughout the cells and their processes, showing the widespread distribution of HERG protein. Similar immunofluorescence patterns were obtained with the T474I, I593R, and G628S mutations. In contrast, cells transfected with the Y611H and V822M mutations display an immunofluorescence staining pattern that is more restricted to a perinuclear region. This restricted intracellular distribution pattern is consistent with the results of the Western blot experiments and shows that the mutant proteins are retained intracellularly.
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Our results provide new data about the biosynthesis patterns of a human, voltage-gated ion channel protein studied in a heterologous mammalian expression system. Wild type HERG channel protein is initially synthesized in the ER as the core-glycosylated precursor form with a molecular mass of 135 kDa. It is then modified in the Golgi apparatus, where it becomes the mature form of the channel with a molecular mass of about 155 kDa. As we noted previously, much of the increased protein size results from the addition of complex oligosaccharides by N-linked glycosylation, although other post-translational modification may occur (6). The 155-kDa protein is then transported into the plasma membrane. The fact that only 155-kDa protein is sensitive to externally applied proteinase K suggests that 155-kDa proteins form functional HERG channels in the cell surface membrane. Therefore, the 155-kDa band observed on Western blot serves as a useful marker to assess HERG protein maturation.
An important finding of the present study is that some LQT-2 disease-causing mutations result in protein processing defects that lead to failure of the channel protein to undergo normal transport to the cell surface. Rather, mutant channels are retained in the ER, where they are rapidly degraded. The Y611H and V822M mutations are examples of this defect. These mutations are most easily identified on Western blot analysis, where they generate only the single lower molecular mass precursor band. Several lines of evidence show that these mutant channels are located intracellularly. They are not sensitive to externally applied proteinase K. The Y611H mutation is not converted to the mature form, as shown in the pulse-chase experiments. The immunolocalization experiments confirm a restricted intracellular distribution for both mutations and suggest that the mutant channels are retained in the ER. The mechanism of the retention of the mutant HERG channel protein in the ER is not identified in these experiments. It is well recognized that export of newly synthesized proteins from the ER to the Golgi is regulated by a "quality control" mechanism (31, 32). This mechanism ensures that only properly folded and assembled proteins leave the ER. Misfolded, unassembled, and incompletely assembled subunit proteins are retained in the ER and undergo degradation without reaching the Golgi complex (33, 34). Thus, the LQT-2 mutations Y611H and V822M may cause structural abnormalities with protein misfolding or improper assembly, and they are retained and degraded in the ER. Whether these channel mutations are capable of forming functional channels is unknown.
Defective protein processing has been recognized as an important
mechanism in some congenital human diseases. For cystic fibrosis transmembrane conductance regulator chloride channels, the most common
mutation is the deletion of phenylalanine at position 508 (F508),
which causes 70% of cystic fibrosis cases. This mutation leads to
retention of the channel protein within the cell and failure of channel
trafficking to the plasma membrane (26). Protein processing defects
have also been shown to be important in the low density lipoprotein
receptor in familial hypercholesterolemia (35), in the
Na+/glucose symporter in glucose-galactose malabsorption
(36), and in several other congenital human diseases (37). Our results with LQT-2 mutations are the first to show this mechanism for a human,
voltage-gated K+ channel.
In addition to transport-deficient mutants, other mechanisms for HERG channel dysfunction in LQT-2 are shown by our findings. The I593R and G628S mutations generate channel proteins that are processed similarly to wild type HERG protein, yet these proteins fail to form functional ion channels. The experiments showing sensitivity of the G628S mutant protein to digestion by proteinase K confirm its cell surface location. The immunolocalization experiments also show immunofluorescence staining patterns throughout the cell and its processes. These mutations are close to the pore region of HERG, which may result in defective channel gating or ion permeation; hence, we conclude that these channels cannot open or conduct ions normally. In a brief report, Nie et al. (38) have suggested that the I593R mutation also is able to insert into the plasma membrane, since epitope-tagged mutant protein can be detected on the cell surface. It is also interesting in our experiments that the I593R mutation causes a weakly stained upper band on Western blot. This could suggest that intracellular protein transport may not be completely normal and that some LQT-2 mutations could have both protein processing and functional defects.
The T474I mutation represents another mechanism of channel dysfunction. This mutation generates HERG current with altered gating properties. The channels activate at more negative voltages (activation V1/2 shifted negatively by 27.3 mV). Although maximum current amplitude was similar to that of wild type current, the peak of the I-V plot was shifted negatively by about 20 mV as shown in Fig. 1C. At more positive voltages, inward rectification was present for both the wild type and T474I mutation, and there was a reduction in outward current for the mutation compared with wild type current. This decrease in current at more positive voltages may account for its QT-prolonging phenotype. This mutation has been proposed to be in the S2-S3 intracellular loop (3) or in the S2 intramembrane domain (39) of the putative channel protein structure. Interestingly, another LQT-2 mutation in the S2 region (N470D) also results in functional channels that gate at more negative voltages (19). These results suggest that the S2 region or adjacent S2-S3 loop contribute to the voltage dependence of HERG channel activation. A role of the S2 region in channel gating also has been reported in other voltage-gated K+ channels (40, 41).
LQT-2 is an autosomal dominant inherited disease with both normal and mutant genes present in patients. The present results were obtained by expressing LQT-2 mutations and wild-type HERG protein as homomultimeric channels. Since HERG proteins are thought to form tetrameric channels, the co-expression of some LQT-2 mutations with wild type HERG is thought to result in dominant negative suppression of HERG current (19). These investigators have shown in Xenopus oocytes that the G628S mutation caused marked dominant negative suppression of HERG current, suggesting co-assembly of the G628S mutant protein with wild type protein. In a preliminary report, Nie et al. (38) also have shown that the I593R mutant is able to co-assemble with the wild type protein. As shown in our experiments, these mutations are processed similarly to wild type HERG channels. Whether the transport-deficient mutants such as Y611H and V822M can co-assemble with wild type HERG protein to cause similar dominant negative suppression is not known and is presently under investigation.
In summary, our data identify three types of defects for HERG mutants in LQT-2: 1) some mutations result in intracellular transport defects with channel proteins retained in the ER; 2) some mutations result in channel proteins that are processed similarly to wild type channels but do not have electrophysiological function; and 3) some mutations result in channel proteins that gate abnormally. These findings provide new information about the molecular mechanisms for HERG channel dysfunction in LQT-2 patients. The mutations with these different mechanisms may result in different severities of LQT clinical phenotypes. More detailed clinical studies are needed to permit correlation of the LQT-2 phenotypes with our molecular findings.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Drs. Gail A. Robertson, James D. Bangs, Shetuan Zhang, Jonathan C. Makielski, and Timothy J. Kamp for helpful advice and discussion.
![]() |
FOOTNOTES |
---|
* This study was supported in part by the Oscar Rennebohm Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
A brief report of this work has appeared (20).
Recipient of an American Heart Association Scientist Development
Grant.
¶ Supported by National Institutes of Health Grant NS31385.
To whom correspondence should be addressed: Dept. of Medicine
(Cardiology), University of Wisconsin Hospital and Clinics, Room
H6/352, 600 Highland Ave., Madison, WI 53792. Tel.: 608-262-5291; E-mail: ctj{at}medicine.wisc.edu.
The abbreviations used are: LQT-2, human chromosome 7-linked congenital long QT; PBS, phosphate-buffered saline; Endo H, endoglycosidase H; ER, endoplasmic reticulum; WT, wild type.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|